Trial · NCT07909174
Turkish Adaptation and Validation of the Scoliosis Misconception Scale in Adolescents With Idiopathic Scoliosis
NCT07909174, Recruiting, Kahramanmaras Sutcu Imam University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Turkish Adaptation and Validation of the Scoliosis Misconception Scale in Adolescents With Idiopathic Scoliosis. Trials, record NCT07909174. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909174
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Turkish Adaptation and Validation of the Scoliosis Misconception Scale in Adolescents With Idiopathic Scoliosis
- NCT number
- NCT07909174
- Status
- Recruiting
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Kahramanmaras Sutcu Imam University
- Conditions
- Adolescent Idiopathic Scoliosis (AIS)
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Internal Consistency of the Turkish Scoliosis Misconception Scale | Baseline (initial assessment) | Internal consistency of the Turkish 17-item Scoliosis Misconception Scale will be assessed using the Kuder-Richardson Formula 20 (KR-20) coefficient for dichotomously scored items (0 = correct response, 1 = incorrect response). Higher total scores indicate a greater number of scoliosis-related misconceptions. Item-total correlations will also be examined. |
| Primary | Test-Retest Reliability of the Turkish Scoliosis Misconception Scale | Baseline and approximately 14 days after baseline | Test-retest reliability will be evaluated in a subgroup of 50 participants who will complete the Turkish Scoliosis Misconception Scale twice, approximately 14 days apart. The agreement between total scores obtained at the two assessments will be examined using the intraclass correlation coefficient (ICC) with a 95% confidence interval. |
| Secondary | Item-Level Psychometric Properties of the Turkish Scoliosis Misconception Scale | Baseline (initial assessment) | Item-level psychometric properties of the Turkish 17-item Scoliosis Misconception Scale will be evaluated using the proportion of incorrect responses for each item and corrected item-total correlations. Each item is scored dichotomously (0 = correct response, 1 = incorrect response). Item-level results will be used to examine response distributions and discrimination within the study sample. |
| Secondary | Item Response Theory Parameters of the Turkish Scoliosis Misconception Scale | Baseline (initial assessment) | Item response theory (IRT) analyses will be conducted to evaluate the measurement properties of the Turkish Scoliosis Misconception Scale. Subject to assessment of model assumptions and parameter estimation adequacy, one-parameter and two-parameter logistic IRT models will be examined. Item difficulty and discrimination parameters, model fit, and test information will be evaluated. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 34341882 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909174
GET https://conductscience.org/api/trials/v1/NCT07909174/registered